Paysign (NASDAQ:PAYS) Receives Hold (C) Rating from Weiss Ratings

Paysign (NASDAQ:PAYS)‘s stock had its “hold (c)” rating reissued by Weiss Ratings in a research note issued to investors on Saturday,Weiss Ratings reports.

Other research analysts have also recently issued research reports about the company. Lake Street Capital lifted their price objective on Paysign from $9.00 to $10.00 and gave the company a “buy” rating in a research note on Wednesday, August 6th. DA Davidson set a $9.00 price objective on Paysign in a research note on Thursday, August 7th. Four investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $8.56.

Paysign Stock Up 4.6%

PAYS opened at $5.94 on Friday. The stock has a market cap of $323.43 million, a PE ratio of 49.50 and a beta of 0.93. The business has a 50 day moving average of $5.57 and a 200-day moving average of $5.19. Paysign has a 52 week low of $1.80 and a 52 week high of $8.88.

Paysign (NASDAQ:PAYS) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.02). The company had revenue of $19.08 million for the quarter, compared to analysts’ expectations of $18.69 million. Paysign had a net margin of 9.90% and a return on equity of 19.32%. Paysign has set its Q3 2025 guidance at EPS. FY 2025 guidance at 0.100-0.120 EPS. Equities analysts anticipate that Paysign will post 0.21 EPS for the current year.

Insider Transactions at Paysign

In other news, CEO Mark Newcomer sold 62,158 shares of the business’s stock in a transaction on Monday, August 4th. The stock was sold at an average price of $7.09, for a total value of $440,700.22. Following the completion of the transaction, the chief executive officer owned 8,750,728 shares in the company, valued at $62,042,661.52. The trade was a 0.71% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Matthew Louis Lanford sold 26,367 shares of the business’s stock in a transaction on Monday, August 4th. The stock was sold at an average price of $7.09, for a total value of $186,942.03. Following the completion of the transaction, the insider owned 147,364 shares of the company’s stock, valued at $1,044,810.76. This represents a 15.18% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 159,602 shares of company stock valued at $1,131,578. Insiders own 22.40% of the company’s stock.

Institutional Trading of Paysign

Several large investors have recently modified their holdings of PAYS. Raymond James Financial Inc. bought a new stake in shares of Paysign in the second quarter worth $30,000. Royce & Associates LP grew its holdings in shares of Paysign by 36.5% in the first quarter. Royce & Associates LP now owns 19,319 shares of the company’s stock worth $41,000 after acquiring an additional 5,166 shares during the period. Jane Street Group LLC bought a new stake in shares of Paysign in the first quarter worth $51,000. Westwood Holdings Group Inc. bought a new stake in shares of Paysign in the second quarter worth $86,000. Finally, Engineers Gate Manager LP bought a new stake in shares of Paysign in the second quarter worth $90,000. Institutional investors own 25.89% of the company’s stock.

About Paysign

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.